Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00738998 · ClinicalTrials.gov registry record · NA
Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT00738998: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT00738998 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00738998, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The goal of this research study is to learn more about what it is like for patients with breast cancer to receive treatment with the drug anastrozole. Researchers want to learn about possible symptoms, such as joint pain, that patients may experience during treatment. Researchers also want to learn more about which patients are most likely to have joint symptoms by looking at certain proteins from routine blood draw samples.
Interventions
- BEHAVIORAL Questionnaire
- OTHER Phone Calls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2008-06-05 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00738998
The ClinicalTrials.gov registry entry for NCT00738998 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00738998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00738998 about?
NCT00738998 is a clinical study titled "Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors". The goal of this research study is to learn more about what it is like for patients with breast cancer to receive treatment with the drug anastrozole. Researchers want to learn about possible symptoms, such as joint pain, that patients may experience during treatment. Researchers also want to learn ...
What is the current status of trial NCT00738998?
This trial is currently terminated. It is a NA study. The enrollment target is 102 participants. The study started on 2008-06-05. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT00738998?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Phone Calls (OTHER).
Who is sponsoring clinical trial NCT00738998?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.